In the era of second generation drug-eluting stents there is no need to extend the duration of dual antiplatelet therapy (DAPT) beyond six months after percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI), a Dutch study has shown. A randomised controlled trial involving 870 patients undergoing primary PCI found that six months of DAPT was ...
Six months of dual antiplatelet therapy safe after PCI: study
By Michael Woodhead
4 Oct 2018